JEN.DEJEN.DEXETRA
Loading
EPS Growth Under PressureDecelerating
Percentile Rank74
5Y CAGR+10.0%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

5Y CAGR
+10.0%/yr
Long-term compound
Percentile
P74
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q3 202542.31%
Q2 202562.50%
Q1 2025-65.96%
Q4 20242.17%
Q3 20249.52%
Q2 202455.56%
Q1 2024-15.62%
Q4 2023-15.79%
Q3 20238.57%
Q2 202366.67%
Q1 2023-16.00%
Q4 2022-16.67%
Q3 2022-23.08%
Q2 2022648.56%
Q1 2022-88.91%
Q4 20210.00%
Q3 2021-16.07%
Q2 2021700.00%
Q1 2021-76.67%
Q4 202025.00%
Q3 202026.32%
Q2 20203068.75%
Q1 2020-101.60%
Q4 201914.29%
Q3 201940.00%
Q2 201938.89%
Q1 2019-68.97%
Q4 201861.11%
Q3 201816.13%
Q2 201814.81%
Q1 2018-44.90%
Q4 201728.95%
Q3 201752.00%
Q2 201766.67%
Q1 2017-51.61%
Q4 20163.33%
Q3 201611.11%
Q2 2016145.45%
Q1 2016-59.26%
Q4 201512.50%